Alliance Development

BIO’s Mission is to be the champion for biotechnology. We advocate for policies that will enable the realization of biotechnology’s promise for providing breakthrough products to cure disease, protecting against bio-terrorism, feeding the hungry, and cleaning our environment.

Lisa Tate, CEO of WomenHeart, the National Coalition for Women with Heart Disease, discusses what we can each do to prevent heart disease.

State governments in 2011 continued to see regional economic growth in the life sciences industry and in 2012 will increasingly focus attention on technology transfer and venture funding as mechanisms to increase private sector innovation related activities within their jurisdictions. Realizing that entrepreneurship is a key ingredient in economic development, states and localities are undertaking the support of programs that assist high technology businesses, and that capitalize on state regional presence of universities and federal laboratories.

Aaron Miscenich, president of the New Orleans BioInnovation Center and chairman of LouisianaBio, discusses the bioscience economic development initiatives.

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The city reached a  milestone its renaissance when the New Orleans BioInnovation Center (NOBIC) opened for business.

With more than one-fifth of the world’s population, China is an important market for biotech products and is increasingly a key global player in biotech research, development and manufacturing.

A strong Network will bolster public awareness of the industry and encourage more investment dollars.

Dr. Augustus White is a pioneer in equitable care. He will be delivering the keynote address at this year’s Diversity Summit at the 2011 BIO International Convention.

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

The keys to successful industrial biotech business relationships mirror those for successful personal relationships, industry leaders explained today.  During the final Lunch Plenary Session of BIO’s 2011 World Congress in Toronto, moderator James Stoppert, CEO of BioAdvisors, along with panelists Patrick Gruber, CEO of Gevo, Ron Commander, Head of Butyl Rubber Business Unit at Lanxess, Christophe Schilling, CEO of Genomatica, and Hisao Urata, General Manager of Corporate Planning at Mitsubishi Chemical discussed “Strategic Partnerships for More Robust Value Chains” and identified some key components to that end.

Partnering decisions can make or break a company’s value. Pursuing the right partnership deal can ultimately increase a company’s value but conversely, the wrong decision can ultimately kill a company’ value.

This month, BIO is leading a delegation of biopharma CEOs to China for meetings with members of the Chinese biotech community and government leaders. The mission illustrates a strong commitment on behalf of the western biotechnology industry to encourage China to strengthen its support for biotech innovation and take steps to enhance greater investment and collaboration with companies in China. The series of meetings between China’s local industry and government leaders and biotech CEOs will lay the foundation for increased cooperation to help biotech flourish in China.

BIO review of this emerging science illustrates progress in applying synthetic biology to improve manufacturing processes.

There are many reasons why more biotech companies belong to BIO than to any other organization. Read on and you’ll see why.

Letters, Testimony & Comments

March 24 2011
March 24, 2011 As our economy begins to improve, job creation remains a critical priority toward ensuring a broad, deep and sustained...
January 13 2011
Re: Microsoft Corp. v. i4i L.P. and Infrastructures for Information Inc., pending in the United States Supreme Court, No. 10-290...
January 11 2011
Dear President Obama: The organizations below urge your Administration to maintain robust funding levels for the Department of...
December 7 2010
Re: IPR and Technology discussions at Cancún Climate Change Talks Dear Secretary Clinton and Ambassador Stern: At this very...
June 1 2010
Dear Chairman Inouye and Ranking Member Cochran: As the Senate debates fiscal year 2011 federal funding, the undersigned organizations...

Press Releases

March 2 2012
WASHINGTON, D.C. (March 2, 2012) – The Biotechnology Industry Organization (BIO) announced today that it has...
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
January 17 2012
The Biotechnology Industry Organization (BIO) announced today that Fritz Bittenbender has been hired to serve as Vice...
June 6 2011
WASHINGTON, D.C. (Tuesday, June 06, 2011) - Today, the United States Supreme Court issued its opinion in the appeal...
February 14 2011
WASHINGTON, D.C. (Monday, February 14, 2011) -A new study released by Biotechnology Industry Organization (BIO)...